![]() |
||
|
Navigation
The 10k London Run
About IDDT
|
You are in:
Home \
Health Issues associated with Diabetes
\ Osteoporosis - Is
There A Link With DiabetesOSTEOPOROSIS – IS THERE A LINK WITH DIABETES?What is osteoporosis? It literally means ‘porous bones’. Our bones are made up of a thick outer shell and a stronger inner mesh of tiny struts of bones and in osteoporosis some of these struts become thin or break. This makes the bone more delicate and likely to break. The most common fractures in people with osteoporosis are wrists, hips and spinal bones. Osteoporosis often goes undetected until a fracture occurs. Causes of osteoporosis There are two types of cells in bones that are constantly working – one group of cells build up new bone and the other breaks down old bone. Calcium and phosphate are essential for normal bone formation and up to the mid-20s uses these minerals to enable the bone-building cells work harder to build strength into the skeleton. If calcium and phosphate intake is insufficient or if the body does not absorb enough calcium from the iet, then bone production and tissue may suffer. As part of the natural aging process, from 40 years onwards the cells that break down bones overtake and bones gradually lose their density. Who is at risk of osteoporosis? It is a common problem and in the UK one in two women and one in five men over 50 will break a bone. It is extremely rare in children, young people and pregnant women. Bone health is largely hereditary but there are factors that can increase the risk of osteoporosis:
Symptoms There are no symptoms of osteoporosis in the early stages. In the late stages the symptoms include:
If you think you are at risk of osteoporosis You should discuss this with your GP. You may need a special scan called a dual energy x-ray absorptiometry (DXA), which measures bone density. It is a simple and painless procedure that is recommended for people at high risk. Osteoporosis diagnosed on a bone density scan does not always mean you are at high risk of bone fractures as other factors such as age, have to be taken into account. Treatment Treatments focus on slowing down or stopping bone loss, preventing bone fractures by reducing the risks of falls and controlling pains associated with having the condition. There is a range of drug treatments to reduce the risk of breaking bones which your doctor will discuss. Note: 21.11.07 A drug to treat osteoarthritis pain has been suspended The Medicines and Healthcare products Regulatory Agency [MHRA] suspended the sales of Prexige because it can damage the liver. It is used to treat osteoarthritis pain and is in the same class of drugs as Vioxx, withdrawn 3 years ago for causing heart attack and stroke. The MHRA advice is that people who are in good health and benefiting from taking Prexige may continue on it but should see their doctor to discuss alternatives but people taking it who feel unwell should stop taking it immediately and see their doctor as soon as possible. Lifestyle changes can also help.
ARE THERE LINKS BETWEEN OSTEOPOROSIS AND DIABETES? A review of 16 studies involving over 800,000 people who sustained a total of nearly 140,000 hip fractures has found that having diabetes, especially Type 1 diabetes, makes people more likely to have hip fractures. The review of 12 studies showed that people with Type 2 diabetes are 70% more likely to fracture their hip and in the review of 6 studies, those with Type 1 over 6 times more likely to do so. The researchers suggest that the cause could be diabetes complications, such as retinopathy, neuropathy, low blood sugars and stroke making people more likely to fall. A study [J Cell Biochem, Nov 2007] refers to bone loss [which can lead to osteoporosis] as ‘a less well-known complication of Type 1 diabetes’ and that there are differences between bone loss in Type 1 diabetes and age-related bone loss. It suggests that possible contributors to the suppression of bone formation in Type 1 diabetes include: increased marrow adiposity, hyperlipidemia, reduced insulin signaling, hyperglycemia, inflammation, altered adipokine and endocrine factors, increased cell death and altered metabolism. Another study carried out in Germany [J. Bone Miner Res. Sept 2007 (9)] has shown the trends of longer life expectancy and a lifestyle of low physical activity and high-energy food intake contribute to an increasing incidence of diabetes and osteoporosis. However, people with newly diagnosed Type 1 diabetes may have impaired bone formation due to the absence of the anabolic effects of insulin and amylin, but in people with long-standing Type 1 diabetes, vascular complications may account for low bone mass and increased fracture risk. It is suggested that prevention of fractures caused by osteoporosis in people with Type 1 diabetes may include tight control of blood glucose levels and aggressive prevention and treatment of vascular complications. People with Type 2 diabetes have an increased fracture risk thought to be caused by increased risk of falling. The research suggests that people with Type 2 diabetes may benefit from early visual assessment, regular exercise to improve muscle strength and balance and specific measures for preventing falls.
Excess body fat may contribute to poor bone health,
according to a new study of 115 young women between 18 and 19 years old.
The finding adds to the growing list of obesity-related health problems,
which already includes an increased risk of heart disease, stroke,
cancer, and others. WARNING: Avandia, a drug to treat Type 2 diabetes may cause increased risk of bone fractures In March 2007 GlaxoSmithKline [GSK] issued a warning to women and doctors of an increased risk of bone fractures when taking Type 2 diabetes medications containing rosiglitazone - sold under the names of Avandia, Avandamet and Avandaryl. The warning came after GSK reviewed the Diabetes Outcome and Progression Trial [ADOPT] in which 4,360 people with Type 2 diabetes were followed for 4-6 years to compare rosiglitazone medications to metformin and glyburide [sulphonylurea] on their own. The trial discovered a pattern of fractures in women taking rosiglitazone which occurred in the upper arm, hands and feet. These are not places where osteoporosis in postmenopausal women is commonly seen - it is usually in the hip or spine. Men in the study taking the three types of rosiglitazone did not show a difference in fracture rates. In the US people using any of these medications are being advised to report fractures as an adverse reaction. It is worth noting that a Cochrane Review of Avandia also found an increased number of bone fractures in women taking the drug. It recommended that if you are a woman, especially if you are this, then you should avoid taking Avandia due to the increased risk of bone fractures. There are other drugs for the treatment of Type 2 diabetes that have not been shown to have this risk. General information about osteoporosis can be obtained from: National Osteoporosis Society, Manor Farm, Skinners Hill, Camerton, Bath, BA2 0PJ
Telephone 01761471771 or e-mail info@nos.org.uk |
|
|
©2003 Insulin Dependent Diabetes Trust | IDDT Home | Contact Us | Registered Charity: 1058284 |